功能磁共振成像在宫颈癌近距离放疗后PET/CT不完全缓解患者中的应用
该回顾性研究纳入244例接受同步放化疗及影像引导高剂量率近距离放疗的宫颈癌患者,探讨PET/CT缓解与预后的关系,并评估弥散加权MRI(DW-MRI)对PET/CT不完全缓解(PET-IR)患者的补充价值。结果显示PET完全缓解(PET-CR)者2年总生存率显著优于PET-IR者,DW-MRI阳性与局部复发及更差生存相关。
要点
- PET/CT完全缓解者2年总生存率94%,不完全缓解者62.4%,差异显著。
- PET-IR患者中32%出现局部复发,DW-MRI阳性者81.8%确认局部复发。
- DW-MRI阴性者2年总生存率83%,阳性者36%,差异有统计学意义。
核心结论
- 影像引导近距离放疗后约20%宫颈癌患者PET/CT显示不完全缓解。
- 整合DW-MRI有助于准确识别持续病灶风险及长期预后较差的患者。
- DW-MRI的价值需在大样本前瞻性数据集中进一步验证。
研究设计与样本
- 回顾性图表审查,纳入2007至2016年间244例FIGO IB1-IVA期宫颈癌患者。
- 患者均接受同步放化疗及影像引导高剂量率近距离放疗,分5次宫腔内/组织间插植,每次5-6 Gy。
主要发现
- 治疗后中位3.3个月(范围2.1-7.7个月)PET/CT完全缓解者50/244例(20%)。
- 中位随访27个月,全组2年总生存率83%。
- PET-IR患者中16/50例(32%)出现局部复发。
- 27例PET-IR患者行DW-MRI,中心判读11/27例(40%)阳性,中位ADC值0.973×10⁻³ mm²/s。
- DW-MRI阳性者9/11例(81.8%)组织学证实局部复发,阴性者2/16例(12.5%)局部复发。
关键数值与推荐
- PET-CR者2年总生存率94%,PET-IR者62.4%,P < .001。
- DW-MRI阴性者2年总生存率83%,阳性者36%,P = .049。
临床怎么用
- 对影像引导近距离放疗后PET/CT不完全缓解的宫颈癌患者,可考虑补充DW-MRI以评估持续病灶风险。
- DW-MRI阳性提示局部复发风险高及长期生存较差,可能有助于早期评估和挽救治疗决策。
局限性
- 回顾性研究设计,DW-MRI仅在部分PET-IR患者中实施(27/50例)。
- DW-MRI的价值尚需大样本前瞻性数据集验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the correlation between positron emission tomography/computed tomography (PET/CT) response and outcome in the era of magnetic resonance imaging (MRI)-based planning and to assess whether the addition of diffusion-weighted MRI (DW-MRI) could more accurately classify treatment response and prognosis. METHODS AND MATERIALS: A retrospective chart review identified 244 consecutive patients with International Federation of Gynecology and Obstetrics stage IB1-IVA cervical cancer treated with concurrent chemoradiation, including high-dose-rate image-based brachytherapy, between 2007 and 2016. Image-based brachytherapy was delivered with 5 intracavitary/interstitial fractions, each 5 to 6 Gy per fraction. RESULTS: An complete response on posttreatment PET/CT (PET-CR) was discovered in 50 of 244 patients (20%) at a median interval of 3.3 months (range, 2.1-7.7 months) after treatment. After a median follow-up of 27 months, 2-year overall survival was 83% in all patients. Metabolic response significantly impacted 2-year overall survival (94% complete response on posttreatment PET/ CT vs 62.4% PET-IR, P < .001). Of those with a PET-IR, 16 of 50 patients (32%) suffered a local recurrence. A total of 27 of 50 patients with a PET-IR underwent DW-MRI; 11 of 27 posttreatment DW-MRI scans (40%) were interpreted as positive by central review (median apparent diffusion coefficient of 0.973 × 10-3 mm2/s). Of the DW-MRI-positive patients, 9 of 11 (81.8%) suffered a histologically confirmed local recurrence, and 2 of 11 patients are without evidence of disease. Additionally, 16 of 27 DW-MRI studies were interpreted as negative, and 2 of 16 (12.5%) of these patients suffered a local recurrence. Diffusion-weighted MRI findings significantly impacted 2-year overall survival (83% negative DW-MRI vs 36% positive DW-MRI, P = .049). CONCLUSION: Incomplete PET/CT response was documented in 20% of patients after image-based brachytherapy for locally advanced cervical cancer. Integration of DW-MRI helped accurately identify patients at risk for persistent disease and worse long-term outcome. The value of DW-MRI requires further validation in a large prospective dataset as this modality may allow earlier evaluation and salvage treatment in those with PET-IR.
引用
- Kalash R, Glaser SM, Rangaswamy B, et al. Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 29559287. doi:10.1016/j.ijrobp.2018.01.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。